BIG PHARMA at work
Home
Shortages in Essential Drugs--Big PhARMA at work
MOST drugs are from China and India
Medical Device Makers cannot be sued, Supreme Court Rules
Ghost writing the norm for over a decade
journal articles are advertising dressed as science--examples
Top 10 Drug Recalls and Warnings of 07
FDA Fraud Program
Big PhARMA ghost writes journal articles
Big PHARMA pays generic manufacturers to not ...
New CANCER drugs add little to life expectancy--why
Big Pharma influences the DSM manual
Most Drugs Now are both Imported and not Tested for Purity
Slash taxes or we move our facilities
RU-486 comes from China, now--more tainted drugs
Antidepressants Proven useless for most
Heart Medication kills 22,000 in 2 years
Statin combination Vytorin doesn't work, etc.
Off Label Drug Pushers
0ff Prescription Market Law Eli Lilly violates for Zyprexa
Price Gouging for Orphan Drugs
Marketing department ran massive drug trial for VIOXX
Direct to consumer spending on the rise
Pharma Lobby and Democrats
U.S. Pharma Moves to China and India
Research and Production moves to China and India
Cancer Generic Drug Shortage increases sales of patented drugs
journal articles are advertising dressed as science--examples

Enter subhead content here

What is described below is true of every developed nation as to journal articles, bias, raw data and their regulatory agencies of those nations.  Regulations have been politicalized in an attempt to make the people believe that the drugs they take are safe and effective.  The article below expose the façade.  The research is owned by the pharmaceutical company which funds the study, and they are free to manipulate the results as they see fit.  The few studies done by the FDA are not better, since they function to promote the pharmaceutical industry.  The article below is a wake-up call to let the reader know what Harvard Prof. Dr. Marcia Angell stated in a lecture:  We certainly are in a health care crisis, ... If we had set out to design the worst system that we could imagine, we couldn't have imagined one as bad as we have.”  The corporate media on rare occasions airs a negate word about their biggest advertiser, and it is done for to create the illusion of being fair and balanced.  This can exist only in a Corporatist State (world)--jk.

Volume 358:252-260, January 17, 2008,  Number 3  http://content.nejm.org/cgi/content/short/358/3/252

Bias http://healthfully.org/index/id9.html Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy between 11-69% average 32%, 12 anti-depressants involving 12,54 patients, published results compared to FDA outcomes.  “According to the literature it appears that 94% of the trials conducted were positive.  By contrast FDA analysis showed that 51% were positive …. studies that were not positive, in our opinion, were often published in a way that conveyed a positive outcome.   The FDA uses raw data from the submitting drug companies for each study. This makes great sense, as the FDA statisticians can then compare their analyses to the analyses from drug companies, in order to make sure that the drug companies were analyzing their data accurately…. Unlike the FDA, journals are not checking raw data.   That is every single drug approved by the FDA for depression between 1987 and 2004. Just a few of many tales of data suppression and/or spinning can be found below:

·                            Data reported on only 1 of 15 participants in an Abilify study

·                            Data hidden for about 10 years on a negative Zoloft for PTSD study

·                            Suicide attempts vanishing from a Prozac study

·                            Long delay in reporting negative results from an Effexor for youth depression study

·                            Data from Abilify study spun in dizzying fashion. Proverbial lipstick on a pig.

·                            A trove of questionable practices involving a key opinion leader

·                            Corcept heavily spins its negative antidepressant trial results

Quality of US health care, WHO comparison http://healthfully.org/index/id1.html  19.3 and 24.1 percent of the total dollars spent on health care in the U.S. is spent simply on administrative costs.—but managed healthcare systems typically allocate 35% to administrative costs and corporate profits.  1998 costs $4,178, 13.6 of GDP, and ranked 40th life expectancy 70.0 (only Denmark lower because of assisted dying with 69.4), Japan 1st with 74.5 years.